<DOC>
	<DOC>NCT00308906</DOC>
	<brief_summary>The purposes of this study are to identify potential gene and protein markers of aminoglycoside-induced kidney injury in infants, children and adolescents treated with aminoglycoside antibiotics.</brief_summary>
	<brief_title>Identification of Gene and Protein Markers of Kidney Injury in Aminoglycoside-treated Children</brief_title>
	<detailed_description />
	<mesh_term>Renal Insufficiency</mesh_term>
	<criteria>(1) Hospitalized male and female newborns, infants, children and adolescents (ages birth to 18 years) with a diagnosis of suspected or proven bacterial sepsis, meningitis or other indication necessitating aminoglycoside therapy (2) hospitalized and outpatient newborns, infants, children and adolescents (ages birth to 18 years) who are not receiving aminoglycoside therapy. (1) Current treatment with inhaled or ophthalmic aminoglycosides (2) Prior treatment with an aminoglycoside within the last 30 days</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>January 2016</verification_date>
	<keyword>infection</keyword>
	<keyword>renal dysfunction</keyword>
	<keyword>aminoglycoside</keyword>
	<keyword>protein</keyword>
	<keyword>child</keyword>
</DOC>